Search Results 881-890 of 18381 for prostate cancer
... cancers, including prostate, kidney, bladder, and testicular cancers. ... prostate cancer; Research interests include biomarker development, molecular ...
rgery, Partial nephrectomy, Laparoscopic kidney surgery, Kidney cancer, Prostate cancer, Bladder cancer, Benign prostatic hyperplasia, Ureteral cancer. Show ...
* Primary diagnosis of prostate cancer selected for surgical intervention (radical prostatectomy) * Primary diagnosis of organ confined (i.e. localized) ...
Patients with high risk prostate cancer, defined by AUA guidelines, who elect robotic assisted radical prostatectomy with an extended pelvic lymph node ...
Findings will help identify patients with breast, ovarian, pancreatic or prostate cancer who may benefit from targeted therapies. ROCHESTER, Minn.
Treatments such as chemotherapy, hormone therapy and immunotherapy have had limited success against advanced prostate cancer due to the tumor's ability to ...
D., is a urologist with an interest in prostate cancer, benign prostatic hyperplasia, and prostate health. He is a urologic surgeon with a clinical practice ...
The purpose of this study is to test how well M1774 works in treating patients with prostate cancer that does not respond to treatment (refractory) and who have ...
Triptorelin is used to treat advanced prostate cancer. It is a hormone that is similar to the one normally released from the hypothalamus gland in the brain.
The purpose of this study is to determine how patients with metastatic castration-resistant prostate cancer, and evidence of a homologous recombination gene ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.